Eris Lifesciences Limited has submitted the Exchange a copy Srutinizers report of undefined held on July 25, 2025
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences filed the scrutinizer's report for its 19th AGM held on July 25, 2025. Eight resolutions were put to vote, of which seven were passed and one (re-appointment of Mr. Krishnakumar Vaidyanathan as Whole-Time Director) was withdrawn. All four ordinary resolutions — adoption of FY25 audited financial statements, appointment of Walker Chandiok & Co. LLP as statutory auditor for FY26 to FY30, ratification of cost auditor remuneration, and appointment of Ravi Kapoor & Associates as secretarial auditor — passed with 100% support. Among the special resolutions, re-appointments of Mr. Inderjeet Singh Negi (97.32%) and Mr. Kaushal Kamlesh Shah (98.50%) as Whole-Time Directors passed with strong support. Re-appointment of Mr. Amit Bakshi as Managing Director received 93.99% support, with 6.01% dissent (about 27.76 lakh shares voted against) and roughly 5.83 crore shares abstaining.
All material business items at the AGM were cleared, with no surprise outcomes for shareholders. The relatively lower approval for the Managing Director's re-appointment and the withdrawal of one director resolution are minor governance watchpoints but are unlikely to materially affect the stock.